Relapsed/Refractory Aggressive B-Cell Lymphoma

Explore clinical trials studying Relapsed/Refractory Aggressive B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed/Refractory Aggressive B-Cell Lymphoma trial results

Not Yet Recruiting

NCT07476066

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Not specified

Completed

NCT02651662

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

Dana Farber/Harvard Cancer Center - PO box 849168 Boston, Massachusetts, United States

Harvard Medical School - Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Cancer & Hematology Centers of Western Michigan Grand Rapids, Michigan, United States

View all 30 locations